Despite REGENXBIO's revenue growth, its significant share pr...
Despite REGENXBIO's revenue growth, its significant share price drop over the past five years suggests possible over-hype. The company's poor performance over the past year, even as the market gained, could be a warning for long-term investors.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002757c137e776f7.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment